Edgewise Therapeutics (EWTX) Analyst & Key Data

Analyst Consensus

Buy16 analysts

Buy

Updated Sep 12, 2026

Total Analysts16

Buy

9

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$44.40

Median Target+3.47%

$45.94

Potential upside vs current price

DCF Value-98.87%

$0.50

Potential downside vs current price

Current Stock Price

$44.40

Median Target+3.47%

$45.94

Potential upside vs current price

DCF Value-98.87%

$0.50

Potential downside vs current price

Analyst Consensus

Buy16 analysts

Buy

Updated Sep 12, 2026

Total Analysts16

Buy

9

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$44.40

Median Target+3.47%

$45.94

Potential upside vs current price

DCF Value-98.87%

$0.50

Potential downside vs current price

Current Stock Price

$44.40

Median Target+3.47%

$45.94

Potential upside vs current price

DCF Value-98.87%

$0.50

Potential downside vs current price

Edgewise Therapeutics, Inc.